Objective To explore the efficacy and safety of the traditional Chinese medicine professor Zhang Liangying?蒺s prescription orally combined with enema in the treatment of sequelae of pelvic inflammatory disease with accumulation of damp-heat. Methods A total of 70 patients with pelvic inflammatory disease sequelae of damp-heat stasis syndrome were selected and randomly divided into a control group and a treatment group, 35 cases in each group. The treatment group was given Professor Zhang Liangying?蒺s experience prescription of Xiaoyan Formula orally combined with Enema Formula for retention enema, while the control group was given Fuke Qianjin Capsule orally. The two groups were treated for 2 consecutive courses, the clinical efficacy and the length of the course of treatment were observed in the two groups, and the changes in the scores after treatment were compared between the two groups. Results The total effective rate of the treatment group was 91.43%, which was significantly higher than 80% of the control group(P<0.05), and the treatment group was better than the control group in improving the clinical symptoms, signs and comprehensive efficacy of the patients(P<0.05), there were no adverse reactions in the two groups of patients during treatment. The comparison between the two groups of disease and curative effect, mild P=0.16, moderate P=0.01, severe P=0.04. Conclusion Prof. Zhang Liangying?蒺s oral administration of Xiaoyan Prescription combined with Enema Prescription combined internal and external therapy with retention enema and Fuke Qianjin Capsule are both effective in treating the sequelae of pelvic inflammatory disease of damp-heat stasis type, but Zhang Laoyan Prescription of Xiaoyan Prescription combined with Enema Prescription and combined internal and external enema can improve traditional Chinese medicine. Symptoms, signs and comprehensive curative effects are better than Fuke Qianjin Capsules, and the curative effect of the treatment group in treating moderate and severe disease is better than that of the control group.